2005.12 |
Dystrophic calcification of the fibrous capsule around a hydrogel explants 13 years after sclera bucking surgery; capsular calcification of a hydrogel explants. |
2006.05 |
Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study |
2011.01 |
Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy |
2011.08 |
Effect of Intravitreal Bevacizumab Based on Optical Coherence Tomography Patterns of Diabetic Macular Edema. |
2011.09 |
Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy |
2012.03 |
Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion |
2012.07 |
Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports |
2013.04 |
Changes of Parafoveal Retinal Nerve Fiber Layer Thickness Analyzed by Spectral Domain Optical Coherence Tomography after Pars plana Vitrectomy |
2013.06 |
Association between Fundus Autofluorescence and Visual Outcome in Surgically Closed Macular Holes. |
2013.05 |
Morphological Change of Inner Retinal Layer on Spectral-Domain Optical Coherence Tomography following Macular Hole Surgery |
2013.06 |
Retinal Neurodegeneration in Type II Diabetic Otsuka Long-Evans Tokushima Fatty Rats |
2013.11 |
New Profiles of Posterior Pole Retinal Thickness Map in Healthy Korean Eyes Measured by Spectral-Domain Optical Coherence Tomography |
2014.02 |
Diurnal Variation in Choroidal Thickness in relation to Sex, Axial Length, and Baseline Choroidal Thickness in Healthy Korean Subjects |
2015.09 |
Topographic Changes in Macular Ganglion Cell-Inner Plexiform Layer Thickness after Vitrectomy with Indocyanine Green Guided Internal Limiting Membrane Peeling for Idiopathic Macular Hole |
2015.12 |
Variations in Choroidal Thickness after High-dose Systemic Corticosteroid Treatment in Children with Chronic Glomerulonephritis |
2016.03 |
Visual and Morphologic Outcomes of Intravitreal Ranibizumab for Diabetic Macular Edema Based on Optical Coherence Tomography Patterns |
2016.04 |
En Face Spectral-Domain Optical Coherence Tomography Imaging of Outer Retinal Hard Exudates in Diabetic Macular Edema Based on Optical Coherence Tomography Patterns |
2016.06 |
Morphologic changes in the retina after selective retina therapy |
2016.10 |
Repeatability and Reproducibility of Spectral-Domain Optical Coherence Tomography Measurements of Retinal Thickness in Rats |
2016.10 |
Retinal neurodegeneration associated with peripheral nerve conduction and autonomic nerve function in diabetic patients |
2016.06 |
Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration |
2016.08 |
Substance P promotes the recovery of oxidative stress-damaged retinal pigmented epithelial cells by modulating Akt/GSK-3β signaling |
2017.01 |
Age-related clinical outcome following macular hole surgery |
2018.06 |
Correlation between preoperative en face optical coherence tomography of photoreceptor layer and visual prognosis after macular hole surgery |
2017.11 |
Clinical characteristics and risk factors for retinal diabetic neurodegeneration in type 2 diabetes |
2018.01 |
Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema |
2019.02 |
Outcome of intravitreal aflibercept for refractory pigment epithelial detachment with or without subretinal fluid and secondary to age-related macular degeneration |
2018.09 |
Optical coherence tomography angiography analysis of foveal microvascular changes and inner retinal layer thinning in patients with diabetes |
2017.12 |
Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α |
2019.02 |
Atypical epiretinal tissue in full-thickness macular holes: pathogenic and prognostic significance |
2018.06 |
Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy |
2019.08 |
Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy |
2018.12 |
Longitudinal relationship between retinal diabetic neurodegeneration and progression of diabetic retinopathy in patients with type 2 diabetes |
2019.02 |
Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics |
2020.10 |
SP prevents T2DM complications by immunomodulation |
2019.09 |
Five-Year Follow-Up of Unaffected Fellow Eyes in Patients with Polypoidal Choroidal Vasculopathy |
2020.05 |
A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography |
2020.07 |
Fundus Autofluorescense Patterns in Central Serous Chorioretinopathy |
2020.12 |
Oral-Facial-Digital Syndrome Type IX with Subfoveal Drusenoid Deposit |
2021.01 |
Longitudinal changes in retinal microvasculature after panretinal photocoagulation in diabetic retinopathy using swept-source OCT angiography |
2021.12 |
Correlation between Topographic Progression of Geographic Atrophy and Visual Acuity Changes |
2020.05 |
Longitudinal Microvascular Changes on Optical Coherence Tomographic Angiography after Macula-Off Rhegmatogenous Retinal Detachment Repair Surgery |
2021.08 |
Automatic segmentation of corneal dystrophy on photographic images based on texture analysis |
2021.06 |
Gap in capillary perfusion and burden of treatment in branch retinal vein occlusion: A widefield optical coherence tomography angiography study |
2021.08 |
Quantification of retinal microvascular parameters by severity of diabetic retinopathy using wide-field swept-source optical coherence tomography angiography |
2021.01 |
Effects of Blue Light on Eye of Zebra Fish and Protective Role of Polyphenolic Compounds |
2021.12 |
Choroidal Changes in Eyes With Polypoidal Choroidal Vasculopathy After Anti-VEGF Therapy Imaged With Swept-Source OCT Angiography |
2021.05 |
Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema |
2021.07 |
Convolutional Network With Twofold Feature Augmentation for Diabetic Retinopathy Recognition From Multi-Modal Images |
2022.02 |
A Smartphone-Based Near-Vision Testing System: Design, Accuracy, and Reproducibility Compared With Standard Clinical Measures |
2022.08 |
The effect of intravitreal dexamethasone implantation on diabetic macular edema refractory to anti-vascular endothelial growth factor treatment |
2022.10 |
Clinical Characteristics and Long-term Outcomes in Diabetic Macular Edema Patients: With or without Additional Injection Following Ranibizumab Loading |